Does the use of per cent of predicted have any evidence base?

Miller Martin R.

Source: Eur Respir J 2015; 45: 322-323

Journal Issue: February

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Miller Martin R.. Does the use of per cent of predicted have any evidence base?. Eur Respir J 2015; 45: 322-323

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Do we have enough evidence overall, or should we wait for ongoing trials? Source: International Congress 2014 – From respiratory infections to wheezing: reevaluating the role of vitamin D levels in childhood Year: 2014
How to protect children from the risk of tuberculosis disease? The contact study. Management suggestions based on a 11 year experience Source: Eur Respir J 2002; 20: Suppl. 38, 549s Year: 2002
What do we need from our patients? - the clinician's point of view Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue Year: 2014
Definition of COPD: based on evidence or opinion? Source: Eur Respir J 2008; 31: 681-682 Year: 2008
Is there enough evidence to support recommendations on tuberculosis control? Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008
What do new data concerning triple therapy tell us about the risk of infection? Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019
What is asthma?COPD overlap syndrome? Towards a consensus definition from a round table discussion Source: Eur Respir J 2016; 48: 664-673 Year: 2016
Evidence provided by recent meta-analyses on treatment: what is new? Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET) Year: 2012
What are the knowledge gaps in COPD that prevent new drug development? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
Is the 6 minute walk test expressed as percent predicted of normal a useful tool for evaluating COPD patients participating in a pulmonary rehabilitation programme? Source: Eur Respir J 2003; 22: Suppl. 45, 330s Year: 2003
Who are the patients who die of COPD with no evidence of prior diagnosis? A UK primary care database analysis. Source: Virtual Congress 2020 – Determinants of chronic respiratory diseases Year: 2020
Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios Source: Eur Respir J 2015; 45: 25-29 Year: 2015
Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018
What type of clinical evidence is needed to assess medical devices? Source: Eur Respir Rev 2016; 25: 259-265 Year: 2016
Is it possible to find a predictor for detecting early signs of an COPD-exacerbation with LT-NIVpatients? Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019
WHO 2019 guidelines on drug-resistant tuberculosis treatment: based on evidence or expert opinion? Source: Eur Respir J, 55 (3) 1901935; 10.1183/13993003.01935-2019 Year: 2020
Easy ways of supporting primary care patients to stop smoking: new findings Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice" Year: 2014
Are estimations of radiomic image markers dispensable due to recent deep learning findings? Source: Eur Respir J, 54 (2) 1901185; 10.1183/13993003.01185-2019 Year: 2019